Opendata, web and dolomites

GreenX4Drug SIGNED

Green Enantioselective Halogenation for Drug Discovery and Manufacture

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "GreenX4Drug" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II 

Organization address
address: CORSO UMBERTO I, 40
city: NAPOLI
postcode: 80138
website: www.unina.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 607˙200 €
 EC max contribution 607˙200 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2018
 Funding Scheme MSCA-RISE
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2023-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II IT (NAPOLI) coordinator 110˙400.00
2    UNIVERSIDAD DE CORDOBA ES (CORDOBA) participant 276˙000.00
3    KELADA PHARMACHEM LIMITED IE (Dublin) participant 220˙800.00

Map

 Project objective

The aim of this project is to bring together subject matter experts from the academic and non-academic sectors to develop and exemplify the use of new catalysts and new green reactions to manufacture important halogenated compounds that could be used in drug discovery and drug production. In order to achieve this objective the proposal brings together 3 partners with complementary skills: University of Naples (UNINA): expertise in medicinal chemistry and drug discovery. KelAda Pharmachem: expertise in green chemistry, chemical batch process development and scale-up. UCO: expertise in process engineering of continuous flow processes. We have broken this proposal into the following separate technical Work Packages:

WP1: Preparation of new catalysts for efficient desymmetrization [WP Leader: UNINA].

WP2: Development of enantiospecific halogenation including Fluorination. [WP Leader: Kelada Pharmachem].

WP3 Drug Candidate, library creation & in vitro testing. [WP Leader: Kelada Pharmachem]

WP4 Development of flow variant and scale-up.[WP Leader: UCO}

The above WP's will be undertaken via a series of interlinked secondment of researchers between the consortium partners and will be complemented by a series of training and other initiatives to facilitate interdisciplinary and inter-sectoral knowledge sharing and exchange.

 Deliverables

List of deliverables.
Appointment of Project Manager Other 2019-06-06 16:40:53

Take a look to the deliverables list in detail:  detailed list of GreenX4Drug deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GREENX4DRUG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GREENX4DRUG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

CONMECH (2019)

Nonsmooth Contact Dynamics

Read More  

NEW MARKETS (2019)

New Market: an exploration into the changing nature of business environments, informal barriers and emerging markets in the post-Soviet region

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More